newsfilter
← Latest News
GlobeNewswire·

Instil Bio to Participate in the 2025 Jefferies Global Healthcare Conference

DALLAS, May 30, 2025 (GLOBE NEWSWIRE) -- Instil Bio, Inc. (NASDAQ:TIL, ", Instil", )), a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies, today announced that Bronson